A Bartolazzi

Summary

Affiliation: Karolinska Institute
Country: Sweden

Publications

  1. ncbi Vla-3 distribution in normal and neoplastic non-lymphoid human tissues
    A Bartolazzi
    Department of Immunology, Immunology, Regina Elena Cancer Institute, Rome, Italy
    Pathol Res Pract 189:387-93. 1993
  2. pmc Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
    A Gasbarri
    1Department of Pathology, St Andrea Hospital, University La Sapienza, Via di Grottarossa 1035, 00189 Rome, Italy
    Br J Cancer 91:1096-104. 2004
  3. ncbi Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
    A Bartolazzi
    Department of Oncology Pathology, Cellular and Molecular Tumor Pathology, Cancer Center Karolinska, CCK R8 04 Karolinska Hospital, 17176, Stockholm, Sweden
    Lancet 357:1644-50. 2001
  4. ncbi CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage
    A Gasbarri
    Laboratory of Immunology, Regina Elena Cancer Institute, 00158 Rome, Italy
    Melanoma Res 13:325-37. 2003
  5. ncbi Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression
    P G Natali
    Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 54:68-72. 1993
  6. ncbi Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors
    A Bartolazzi
    Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 58:488-91. 1994
  7. ncbi Generation and characterization of the murine monoclonal antibody M-KID 2 to VLA-3 integrin
    A Bartolazzi
    Laboratory of Immunology, Regina Elena Cancer Institute, Rome, Italy
    Hybridoma 10:707-20. 1991
  8. ncbi Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors
    A Bartolazzi
    Department of Immunology, Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 64:248-52. 1995
  9. ncbi Association of HLA class I and class II antigen expression and mortality in uveal melanoma
    C Ericsson
    St. Erik's Eye Hospital, Stockholm, Sweden
    Invest Ophthalmol Vis Sci 42:2153-6. 2001
  10. ncbi Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression
    B Brodin
    Cellular and Molecular Tumor Pathology, Cancer Centrum Karolinska, CCK R8 04, Karolinska Hospital, SE 171 76, Stockholm, Sweden
    Gene 268:173-82. 2001

Collaborators

Detail Information

Publications12

  1. ncbi Vla-3 distribution in normal and neoplastic non-lymphoid human tissues
    A Bartolazzi
    Department of Immunology, Immunology, Regina Elena Cancer Institute, Rome, Italy
    Pathol Res Pract 189:387-93. 1993
    ..Analysis of Vla-3 expression in established tumor cell lines demonstrated that the integrin is almost invariably expressed by the plastic adherent cell subpopulations...
  2. pmc Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
    A Gasbarri
    1Department of Pathology, St Andrea Hospital, University La Sapienza, Via di Grottarossa 1035, 00189 Rome, Italy
    Br J Cancer 91:1096-104. 2004
    ....
  3. ncbi Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
    A Bartolazzi
    Department of Oncology Pathology, Cellular and Molecular Tumor Pathology, Cancer Center Karolinska, CCK R8 04 Karolinska Hospital, 17176, Stockholm, Sweden
    Lancet 357:1644-50. 2001
    ..We undertook an international multicentre study to assess the usefulness of immunohistocytochemical staining for two potential markers of malignant thyrocytes...
  4. ncbi CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage
    A Gasbarri
    Laboratory of Immunology, Regina Elena Cancer Institute, 00158 Rome, Italy
    Melanoma Res 13:325-37. 2003
    ..Our findings demonstrate that the post-translational modification of CD44s represents the principal regulatory mechanism of CD44s-mediated functions in melanoma...
  5. ncbi Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression
    P G Natali
    Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 54:68-72. 1993
    ..These findings provide additional evidence that tumor progression in CMM is associated with changes in integrin phenotypes which include the alpha 3/beta 1 heterodimer...
  6. ncbi Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors
    A Bartolazzi
    Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 58:488-91. 1994
    ..The highly conserved expression of alpha 3/beta 1 shown in this study suggests that this receptor may play a role in tumor growth at the primary as well as at the metastatic site...
  7. ncbi Generation and characterization of the murine monoclonal antibody M-KID 2 to VLA-3 integrin
    A Bartolazzi
    Laboratory of Immunology, Regina Elena Cancer Institute, Rome, Italy
    Hybridoma 10:707-20. 1991
    ..These findings demonstrate that mAb M-KID 2 can represent a valuable reagent for the study of Vla-3 integrin in normal and pathologic conditions...
  8. ncbi Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors
    A Bartolazzi
    Department of Immunology, Regina Elena Cancer Institute, Rome, Italy
    Int J Cancer 64:248-52. 1995
    ..A selective loss of nicein in basement membranes was demonstrated in NSCLC indicating an impairment of expression of this glycoprotein following malignant transformation...
  9. ncbi Association of HLA class I and class II antigen expression and mortality in uveal melanoma
    C Ericsson
    St. Erik's Eye Hospital, Stockholm, Sweden
    Invest Ophthalmol Vis Sci 42:2153-6. 2001
    ....
  10. ncbi Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression
    B Brodin
    Cellular and Molecular Tumor Pathology, Cancer Centrum Karolinska, CCK R8 04, Karolinska Hospital, SE 171 76, Stockholm, Sweden
    Gene 268:173-82. 2001
    ..This was also observed in a synovial sarcoma tumor expressing SYT/SSX4. This suggests that the SYT/SSX fusion gene may regulate SYT expression from the normal allele and as such alter the normal function of SYT...
  11. ncbi [Molecular diagnosis of synovial sarcoma]
    M P Martegani
    Ospedale S Andrea, II Facolta di Medicina, Universita La Sapienza, Via di Grottarossa 1035 1039, I 00189 Roma, Italia
    Pathologica 94:257-62. 2002
  12. doi Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness
    A Ulivieri
    Research Centre, S Pietro Fatebenefratelli Hospital, Rome, Italy
    J Pathol 215:87-96. 2008
    ..In addition, FZD-1 RNA interference in the PTC-derived cell line K1 increased invasiveness. Our data indicated that FZD-1 is involved in growth of follicular tumours and may be considered as a novel marker of this type of tumour...